Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL03
- Pharmacological subgroupL03A
- Chemical subgroupL03AB
- Chemical substanceL03AB07Interferon beta-1a
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 13 registrations
- Avonex30 MCG / 0.5 ML · Solution · Biogen Canada INC
- Betaseron0.3 MG / VIAL · Powder For Solution · Bayer INC
- Rebif132 MCG / 1.5 ML · Solution · Emd Serono, A Division of Emd INC., Canada
- Rebif22 MCG / 0.5 ML · Solution · Emd Serono, A Division of Emd INC., Canada
Serbia
ALIMS · 11 registrations
At a glance
- ATC code
- L03AB07
- Registers
- 10
- Historical lists
- 2
- Registrations
- 89
- With their own page
- 56
- Companies
- 30
All medicines with Interferon beta-1a
Human medicines from every register that match Interferon beta-1a by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
90 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Avonex | United States | 30MCG/0.5ML | Injection | Marketed | Biogen Inc. |
| Avonex | United States | 1A 30UG/ML | vial | Marketed | Biogen |
| Avonex | United States | 30MCG/0.5ML | Injection | Marketed | Biogen Inc. |
| Rebif | United States | 22MCG/0.5ML | Injection | Marketed | EMD Serono, Inc. |
| Rebif | United States | 8.8MCG/0.2ML | Injection | Marketed | EMD Serono, Inc. |
| Rebif | United States | 1A 22UG/0.5ML, 1A 44UG/0.5ML | syringe | Marketed | Serono INC |
| Rebif | United States | 44MCG/0.5ML | Injection | Marketed | EMD Serono, Inc. |
| Rebif | United States | 8.8MCG/0.2ML | Injection | Marketed | EMD Serono, Inc. |
| Betaferon | European Union | Authorised | Bayer AG | ||
| Betaseron | United States | 1B 0.3 MG | vial | Marketed | Bayer Healthcare Pharms |
| Betaseron | Canada | 0.3 MG / VIAL | Powder For Solution | Marketed | Bayer INC |
| Betaferon® | Serbia | 250mcg/mL | prašak i rastvarač za rastvor za injekciju | Authorised | Bayer D.O.O. Beograd |
| Betaferon | Croatia | Marketed | |||
| BETAFERON 250 microgramos/ml, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | Spain | 250 µg | polvo y disolvente para solución inyectable | Marketed | Bayer Ag |
| Betaferon 250 Microgramos/ML Polvo y Disolvente Para Solucion Inyectable | Spain | 250 µg | polvo y disolvente para solución inyectable | Marketed | Bayer Ag |
| Betaferon | New Zealand | Inj 8 million iu per 1 ml | Funded | ||
| Betaferon, poeder en oplosmiddel voor oplossing voor injectie | Netherlands | Poeder en oplosmiddel voor oplossing voor injectie | Authorised | Bayer AG | |
| BETAFERON 250 microgramos/ml, POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | Spain | 250 µg | polvo y disolvente para solución inyectable | Authorised | Bayer Ag |
| Rebif 22 Microgramos/0,5 ML Solucion Inyectable en Cartucho | Spain | 22 µg | solución inyectable en cartucho | Marketed | Merck Europe B.V. |
| REBIF 44 microgramos/0,5 ml SOLUCION INYECTABLE EN CARTUCHO | Spain | 44 µg | solución inyectable en cartucho | Marketed | Merck Europe B.V. |
| Rebif 44 Microgramos/0,5 ML Solucion Inyectable en Cartucho | Spain | 44 µg | solución inyectable en cartucho | Marketed | Merck Europe B.V. |
| AVONEX 30 microgramos/0,5 ml SOLUCION INYECTABLE EN PLUMA PRECARGADA | Spain | 30 µg | solución inyectable en pluma precargada | Marketed | Biogen Netherlands B.V. |
| Avonex | European Union | Authorised | Biogen Netherlands B.V. | ||
| Rebif | European Union | Authorised | Merck Europe B.V. | ||
| AVONEX 30 microgramos/0,5 ml SOLUCION INYECTABLE | Spain | 0,3 µg | solución inyectable en jeringa precargada | Authorised | Biogen Netherlands B.V. |